Literature DB >> 31782844

Biomaterials as Tools to Decode Immunity.

Haleigh B Eppler1,2, Christopher M Jewell1,2,3,4,5,6.   

Abstract

The immune system has remarkable capabilities to combat disease with exquisite selectivity. This feature has enabled vaccines that provide protection for decades and, more recently, advances in immunotherapies that can cure some cancers. Greater control over how immune signals are presented, delivered, and processed will help drive even more powerful options that are also safe. Such advances will be underpinned by new tools that probe how immune signals are integrated by immune cells and tissues. Biomaterials are valuable resources to support this goal, offering robust, tunable properties. The growing role of biomaterials as tools to dissect immune function in fundamental and translational contexts is highlighted. These technologies can serve as tools to understand the immune system across molecular, cellular, and tissue length scales. A common theme is exploiting biomaterial features to rationally direct how specific immune cells or organs encounter a signal. This precision strategy, enabled by distinct material properties, allows isolation of immunological parameters or processes in a way that is challenging with conventional approaches. The utility of these capabilities is demonstrated through examples in vaccines for infectious disease and cancer immunotherapy, as well as settings of immune regulation that include autoimmunity and transplantation.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  immunology; immunotherapy; microparticles; nanoparticles; organ-on-a-chip; organoids

Mesh:

Substances:

Year:  2019        PMID: 31782844      PMCID: PMC7124992          DOI: 10.1002/adma.201903367

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  125 in total

1.  A microengraving method for rapid selection of single cells producing antigen-specific antibodies.

Authors:  J Christopher Love; Jehnna L Ronan; Gijsbert M Grotenbreg; Annemarthe G van der Veen; Hidde L Ploegh
Journal:  Nat Biotechnol       Date:  2006-05-14       Impact factor: 54.908

2.  Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.

Authors:  Xiqin Yang; Keke Lian; Tingting Meng; Xuan Liu; Jing Miao; Yanan Tan; Hong Yuan; Fuqiang Hu
Journal:  ACS Appl Mater Interfaces       Date:  2018-09-19       Impact factor: 9.229

3.  Mapping the human DC lineage through the integration of high-dimensional techniques.

Authors:  Peter See; Charles-Antoine Dutertre; Jinmiao Chen; Patrick Günther; Naomi McGovern; Sergio Erdal Irac; Merry Gunawan; Marc Beyer; Kristian Händler; Kaibo Duan; Hermi Rizal Bin Sumatoh; Nicolas Ruffin; Mabel Jouve; Ester Gea-Mallorquí; Raoul C M Hennekam; Tony Lim; Chan Chung Yip; Ming Wen; Benoit Malleret; Ivy Low; Nurhidaya Binte Shadan; Charlene Foong Shu Fen; Alicia Tay; Josephine Lum; Francesca Zolezzi; Anis Larbi; Michael Poidinger; Jerry K Y Chan; Qingfeng Chen; Laurent Rénia; Muzlifah Haniffa; Philippe Benaroch; Andreas Schlitzer; Joachim L Schultze; Evan W Newell; Florent Ginhoux
Journal:  Science       Date:  2017-05-04       Impact factor: 47.728

4.  Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors.

Authors:  Joshua M Gammon; Arjun R Adapa; Christopher M Jewell
Journal:  J Biomed Mater Res A       Date:  2017-07-14       Impact factor: 4.396

Review 5.  HIV broadly neutralizing antibody targets.

Authors:  Constantinos Kurt Wibmer; Penny L Moore; Lynn Morris
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

Review 6.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Effect of pore structure of macroporous poly(lactide-co-glycolide) scaffolds on the in vivo enrichment of dendritic cells.

Authors:  Jaeyun Kim; Weiwei Aileen Li; Warren Sands; David J Mooney
Journal:  ACS Appl Mater Interfaces       Date:  2014-06-02       Impact factor: 9.229

8.  Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses.

Authors:  Mahboubeh Ebrahimian; Maryam Hashemi; Mohsen Maleki; Gholamreza Hashemitabar; Khalil Abnous; Mohammad Ramezani; Alireza Haghparast
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

9.  Pathological conversion of regulatory T cells is associated with loss of allotolerance.

Authors:  Jing Hua; Takenori Inomata; Yihe Chen; William Foulsham; William Stevenson; Tina Shiang; Jeffrey A Bluestone; Reza Dana
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

Review 10.  Single-cell RNA sequencing technologies and bioinformatics pipelines.

Authors:  Byungjin Hwang; Ji Hyun Lee; Duhee Bang
Journal:  Exp Mol Med       Date:  2018-08-07       Impact factor: 8.718

View more
  10 in total

1.  Self-Assembly as a Molecular Strategy to Improve Immunotherapy.

Authors:  Eugene Froimchuk; Sean T Carey; Camilla Edwards; Christopher M Jewell
Journal:  Acc Chem Res       Date:  2020-10-19       Impact factor: 22.384

2.  Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines.

Authors:  Daniel Shae; Jessalyn J Baljon; Mohamed Wehbe; Plamen P Christov; Kyle W Becker; Amrendra Kumar; Naveenchandra Suryadevara; Carcia S Carson; Christian R Palmer; Frances C Knight; Sebastian Joyce; John T Wilson
Journal:  ACS Nano       Date:  2020-07-31       Impact factor: 15.881

3.  Biomaterial-enabled induction of pancreatic-specific regulatory T cells through distinct signal transduction pathways.

Authors:  Sean T Carey; Joshua M Gammon; Christopher M Jewell
Journal:  Drug Deliv Transl Res       Date:  2021-10-05       Impact factor: 4.617

4.  Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccination.

Authors:  James I Andorko; Shannon J Tsai; Joshua M Gammon; Sean T Carey; Xiangbin Zeng; Emily A Gosselin; Camilla Edwards; Shrey A Shah; Krystina L Hess; Christopher M Jewell
Journal:  Biomater Sci       Date:  2022-08-09       Impact factor: 7.590

5.  Design of Dissolvable Microneedles for Delivery of a Pfs47-Based Malaria Transmission-Blocking Vaccine.

Authors:  Lampouguin Yenkoidiok-Douti; Carolina Barillas-Mury; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2021-02-22

Review 6.  Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy.

Authors:  Jie Li; Yiqian Luo; Baoqin Li; Yuanliang Xia; Hengyi Wang; Changfeng Fu
Journal:  Front Bioeng Biotechnol       Date:  2020-11-30

Review 7.  Emerging vaccine nanotechnology: From defense against infection to sniping cancer.

Authors:  Chan Feng; Yongjiang Li; Bijan Emiliano Ferdows; Dylan Neal Patel; Jiang Ouyang; Zhongmin Tang; Na Kong; Enguo Chen; Wei Tao
Journal:  Acta Pharm Sin B       Date:  2022-01-04       Impact factor: 14.903

Review 8.  Nanotechnology-enhanced immunotherapy for metastatic cancer.

Authors:  Peisen Zhang; Junli Meng; Yingying Li; Chen Yang; Yi Hou; Wen Tang; Kevin J McHugh; Lihong Jing
Journal:  Innovation (Camb)       Date:  2021-10-14

9.  Mapping the Mechanical and Immunological Profiles of Polymeric Microneedles to Enable Vaccine and Immunotherapy Applications.

Authors:  Shrey A Shah; Robert S Oakes; Senta M Kapnick; Christopher M Jewell
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 8.786

Review 10.  Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.

Authors:  Pengxiang Yang; Yong Peng; Yuan Feng; Zhuoying Xu; Panfeng Feng; Jie Cao; Ying Chen; Xiang Chen; Xingjian Cao; Yumin Yang; Jing Jie
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.